Proof-of-Concept Trial for X-Linked Chronic Granulomatous Disease Treatment Shows Promise
<a href="https://pixabay.com/users/wewewegrafikbaydeh/">wewewegrafikbaydeh</a> / Pixabay

Proof-of-Concept Trial for X-Linked Chronic Granulomatous Disease Treatment Shows Promise

According to a story from Markets Insider, the biopharmaceutical company Orchard Therapeutics recently announced the presentation of proof-of-concept data in regards to their investigational drug candidate OTL-102. This experimental therapy…

Continue Reading
Close Menu